In vivo assessment of the role of aggregated tau in preclinical and prodromal Alzheimer's disease [ 2016 - 2020 ]

Research Grant

Researchers: Dr Andrew Watt (Principal investigator)

Brief description Subtle changes in the brain precede an Alzheimer’s disease (AD) diagnosis by 20-30 years. These changes provide an incredible opportunity to diagnose and treat AD; however, our understanding of them, remains limited. We aim to use new imaging technologies to investigate these subtle changes in the preclinical AD brain. This will give us a greater understanding of how these early changes effect AD progression and whether we can use this information to improve the diagnosis and treatment of AD.

Funding Amount $AUD 612,269.00

Funding Scheme Targeted Calls

Notes NHMRC-ARC Dementia Research Development Fellowship